Related content

Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR

By Rubenstein Marvin  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1212-1218

Humana Press, Inc

Access to resources Recommend Favorite

Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib

By                        

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 835-841

Spandidos Publications

Access to resources Recommend Favorite

LNCaP Human Prostate Cancer Progression Model

By Chung L.W.K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 2, Iss. 4, 1996-07 ,pp. : 126-128

Elsevier

Access to resources Recommend Favorite

Overexpression of cMet increases the tumor invasion of human prostate LNCaP cancer cells in vitro and in vivo

By          

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1618-1624

Spandidos Publications

Access to resources Recommend Favorite

The binding characteristics of a cyclic nonapeptide, c(CGRRAGGSC), in LNCaP human prostate cancer cells

By            

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 443-449

Spandidos Publications

Access to resources Recommend Favorite